U.S.-EU Safe Harbor Renegotiation Deadline Passes: What Now?
Client Alert | 1 min read | 02.01.16
Despite intensive last-minute talks over the weekend, U.S. and European Union (EU) negotiators have yet to reach a new agreement for the legitimization of data transfers from Europe to the United States to replace the invalidated U.S.-EU Safe Harbor Framework (Safe Harbor). On February 1, EU Commissioner Věra Jourová provided a status update at a plenary meeting of the European Parliament's Committee on Civil Liberties, Justice and Home Affairs (LIBE) in Brussels. Jourová told the Parliament committee, "I believe the close relationship between the United States and European Union deserves these special efforts. We are close but an additional effort is needed." Negotiators on both sides still hope to find an agreement this week.
In the meantime, the EU Member States' Data Protection authorities (Article 29 Working Party) will meet on February 2 to discuss how to proceed. The meeting will include discussions about investigations and possible suspensions of data transfers which continue based solely on the former Safe Harbor. The authorities will also assess other transfer mechanisms such as EU Standard Contractual Clauses and Binding Corporate Rules, which also have been criticized based on the same concerns relating to U.S. government surveillance.
We will provide additional guidance as it becomes available.
Contacts
Insights
Client Alert | 3 min read | 09.15.26
Until recently, Belgian law did not have a general regulatory framework for internal investigations. Companies wishing to conduct an investigation had to navigate a fragmented set of rules that covered general principles and, to a limited extent, privacy and employee rights. The application of these rules to internal investigations was not clear, and it was therefore often difficult to put the rules into practice. This legal vacuum created significant risks, both for the integrity of the investigation itself and for the admissibility of any evidence gathered.
Client Alert | 7 min read | 09.14.26
AI in Life Sciences: Ten Legal Considerations and Risks of AI Use in Drug Discovery and Development
Client Alert | 6 min read | 09.14.26
Mental Health Parity Bulletin Restates Best Practices for Evaluating Compliance
Client Alert | 6 min read | 09.11.26
It’s LIVE: The Cyber Resilience Act Reporting Is Mandatory as of Today - 11 September 2026


